These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9377663)

  • 1. [Activity of antithrombin III in the blood of patients with bladder cancer].
    Zietek Z; Iwan-Zietek I; Kotschy M; Wiśniewska E; Tyloch F
    Pol Merkur Lekarski; 1997 Apr; 2(10):268-9. PubMed ID: 9377663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antithrombin III activity in blood of patients with renal cancer].
    Zietek Z; Iwan-Zietek I; Kotschy M; Wiśniewska E; Tyloch F
    Pol Merkur Lekarski; 1997 Jan; 2(9):191-2. PubMed ID: 10907025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The activity of protein C in the blood of patients with bladder carcinoma].
    Iwan-Zietek I; Zietek Z; Kotschy M; Wolski Z; Chodakowska-Akolińska G
    Pol Merkur Lekarski; 1997 Jan; 2(9):193-5. PubMed ID: 10907026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte tissue factor levels in cancer patients.
    Lwaleed BA; Francis JL; Chisholm M
    Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiological evaluation of thromboembolic risk. Critical review of the prospects offered by determination of antithrombin III].
    Gabrielli L; Lorenzi G; Sarcina A; Rossi E; Margstakler E; Mondonico P
    Minerva Med; 1980 Jan; 71(2):83-8. PubMed ID: 7354931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surveillance of women taking oral contraceptives by determination of antithrombin III].
    Benoit MO; Raichvarg D; Caillens H; Neau C
    Nouv Presse Med; 1979 Feb; 8(7):528-9. PubMed ID: 461171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study].
    Enta K; Iwade K; Aosaki M; Uchida T; Kasanuki H
    J Cardiol; 2004 Dec; 44(6):223-32. PubMed ID: 15638220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer].
    Szajda SD; Darewicz B; Kudelski J; Chlabicz M; Domel T; Chabielska E; Skrzydlewski Z
    Pol Merkur Lekarski; 2005 Jun; 18(108):651-3. PubMed ID: 16124376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arterial embolization in the treatment of bleeding uterine and bladder neoplasms].
    Suvorova IuV; Tarazov PG
    Vestn Rentgenol Radiol; 1999; (1):30-4. PubMed ID: 12717888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coagulation parameters in patients with hypertension].
    García E; Rodríguez M; Díez ML; Navarro A
    Rev Esp Fisiol; 1982; 38 Suppl():277-80. PubMed ID: 7146584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the values of antithrombin III and other blood coagulation indices in liver cirrhosis without ascites and in the ascitic stage].
    Doncheva N
    Vutr Boles; 1989; 28(4):96-9. PubMed ID: 2596116
    [No Abstract]   [Full Text] [Related]  

  • 12. Thromboembolism and bleeding in bladder cancer.
    Fantony JJ; Inman BA
    Oncology (Williston Park); 2014 Oct; 28(10):847-54. PubMed ID: 25323610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III activity in cerebrovascular accidents.
    Singh VP; Singh MK; Kumar V; Sinha MK; Dwivedi RC; Rai M; Dube B
    J Assoc Physicians India; 2003 Mar; 51():268-71. PubMed ID: 12839349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The type of anesthesia and intravascular blood coagulation during the surgical treatment of bladder cancer patients].
    Popov AI
    Vopr Onkol; 1987; 33(7):90-4. PubMed ID: 3617616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombin-antithrombin III complexes in plasma and subretinal fluid in patients with perforated retinal detachment].
    Malukiewicz-Wiśniewska G; Kotschy M
    Klin Oczna; 2000; 102(4):267-70. PubMed ID: 11291298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hydrostatic pressure treatment of severe bladder hemorrhage].
    Fåborg-Andersen J; Høgh J
    Ugeskr Laeger; 1980 Feb; 142(8):513-4. PubMed ID: 7368404
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of platelet activation, plasma antithrombin III and alpha2-antiplasmin activities in hypertensive patients.
    Tomczykowska M; Bielak J; Bodys A
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):15-20. PubMed ID: 15314952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hydrostatic hypertension. Method for the control of intractable bladder hemorrhage].
    Pertusa C; Hidalgo L; Silva J; Gómez-Zancajo VR; Martínez-Piñeiro JA
    Actas Urol Esp; 1979; 3(2):117-20. PubMed ID: 474241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.